98 related articles for article (PubMed ID: 22047802)
1. The arginine mimicking β-amino acid β³hPhe(3-H₂N-CH₂) as S1 ligand in cyclotheonamide-based β-tryptase inhibitors.
Janke D; Sommerhoff CP; Schaschke N
Bioorg Med Chem; 2011 Dec; 19(23):7236-43. PubMed ID: 22047802
[TBL] [Abstract][Full Text] [Related]
2. Upgrading a natural product: inhibition of human beta-tryptase by cyclotheonamide analogues.
Schaschke N; Sommerhoff CP
ChemMedChem; 2010 Mar; 5(3):367-70. PubMed ID: 20077463
[No Abstract] [Full Text] [Related]
3. Cyclotheonamide E4 and E5, new potent tryptase inhibitors from an Ircinia species of sponge.
Murakami Y; Takei M; Shindo K; Kitazume C; Tanaka J; Higa T; Fukamachi H
J Nat Prod; 2002 Mar; 65(3):259-61. PubMed ID: 11908961
[TBL] [Abstract][Full Text] [Related]
4. A new approach to inhibit human β-tryptase by protein surface binding of four-armed peptide ligands with two different sets of arms.
Jiang QQ; Bartsch L; Sicking W; Wich PR; Heider D; Hoffmann D; Schmuck C
Org Biomol Chem; 2013 Feb; 11(10):1631-9. PubMed ID: 23358683
[TBL] [Abstract][Full Text] [Related]
5. Affinity chromatography of tryptases: design, synthesis and characterization of a novel matrix-bound bivalent inhibitor.
Schaschke N; Gabrijelcic-Geiger D; Dominik A; Sommerhoff CP
Chembiochem; 2005 Jan; 6(1):95-103. PubMed ID: 15593113
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor.
Scarpi D; McBride JD; Leatherbarrow RJ
Bioorg Med Chem; 2004 Dec; 12(23):6045-52. PubMed ID: 15519150
[TBL] [Abstract][Full Text] [Related]
7. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.
Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM
J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554
[TBL] [Abstract][Full Text] [Related]
8. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
Bhunia SS; Roy KK; Saxena AK
J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
Miyazaki Y; Kato Y; Manabe T; Shimada H; Mizuno M; Egusa T; Ohkouchi M; Shiromizu I; Matsusue T; Yamamoto I
Bioorg Med Chem Lett; 2006 Jun; 16(11):2986-90. PubMed ID: 16540315
[TBL] [Abstract][Full Text] [Related]
10. Mast cell tryptase beta as a target in allergic inflammation: an evolving story.
Sommerhoff CP; Schaschke N
Curr Pharm Des; 2007; 13(3):313-32. PubMed ID: 17313363
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase.
Bisacchi GS; Slusarchyk WA; Bolton SA; Hartl KS; Jacobs G; Mathur A; Meng W; Ogletree ML; Pi Z; Sutton JC; Treuner U; Zahler R; Zhao G; Seiler SM
Bioorg Med Chem Lett; 2004 May; 14(9):2227-31. PubMed ID: 15081014
[TBL] [Abstract][Full Text] [Related]
12. A fluorescent light-up probe as an inhibitor of intracellular β-tryptase.
Wang Q; Shi X; Zhu X; Ehlers M; Wu J; Schmuck C
Chem Commun (Camb); 2014 Jun; 50(46):6120-2. PubMed ID: 24776645
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of the contribution of active site and exosite interactions to affinity and specificity of peptidylic serine protease inhibitors using non-natural arginine analogs.
Hosseini M; Jiang L; Sørensen HP; Jensen JK; Christensen A; Fogh S; Yuan C; Andersen LM; Huang M; Andreasen PA; Jensen KJ
Mol Pharmacol; 2011 Oct; 80(4):585-97. PubMed ID: 21719463
[TBL] [Abstract][Full Text] [Related]
14. Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of novel spirocyclic piperidine amide derivatives.
Costanzo MJ; Yabut SC; Zhang HC; White KB; de Garavilla L; Wang Y; Minor LK; Tounge BA; Barnakov AN; Lewandowski F; Milligan C; Spurlino JC; Abraham WM; Boswell-Smith V; Page CP; Maryanoff BE
Bioorg Med Chem Lett; 2008 Mar; 18(6):2114-21. PubMed ID: 18272363
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided design of peptide-based tryptase inhibitors.
McGrath ME; Sprengeler PA; Hirschbein B; Somoza JR; Lehoux I; Janc JW; Gjerstad E; Graupe M; Estiarte A; Venkataramani C; Liu Y; Yee R; Ho JD; Green MJ; Lee CS; Liu L; Tai V; Spencer J; Sperandio D; Katz BA
Biochemistry; 2006 May; 45(19):5964-73. PubMed ID: 16681368
[TBL] [Abstract][Full Text] [Related]
16. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
17. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.
Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE
J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148
[TBL] [Abstract][Full Text] [Related]
18. 1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase.
Wong T; Groutas CS; Mohan S; Lai Z; Alliston KR; Vu N; Schechter NM; Groutas WC
Arch Biochem Biophys; 2005 Apr; 436(1):1-7. PubMed ID: 15752703
[TBL] [Abstract][Full Text] [Related]
19. Engineering potent mesotrypsin inhibitors based on the plant-derived cyclic peptide, sunflower trypsin inhibitor-1.
de Veer SJ; Li CY; Swedberg JE; Schroeder CI; Craik DJ
Eur J Med Chem; 2018 Jul; 155():695-704. PubMed ID: 29936356
[TBL] [Abstract][Full Text] [Related]
20. Dimerization of β-tryptase inhibitors, does it work for both basic and neutral P1 groups?
Liang G; Choi-Sledeski YM; Chen X; Gong Y; MacMillan EW; Tsay J; Sides K; Cairns J; Kulitzscher B; Aldous DJ; Morize I; Pauls HW
Bioorg Med Chem Lett; 2012 May; 22(9):3370-6. PubMed ID: 22483389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
